One of my concerns over recent months was the fact there were so many other trials under way. From Bioshares, 398 open trial of which 246 are combination trials. Good news is that I take the 2nd page to mean "the only better result (of all these combination or other trials - my understanding) ..."was when Yervoy was combined with Opdivo. That was marginally a better result but with much worse side effects (55% v 6%). Not sure I had read any comparison to all other trials before. May have missed it or even misinterpreted this report (not a medic).
It is frustrating that the summary talks about potentially initiating additional Phase 1B studies or a pivotal study. Surely we have to be at the pivotal trial (somehow financed) by now. Cannot see any benefit in more Phase 1b studies.
Rgds
K
One of my concerns over recent months was the fact there were so...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)